Fundraising Fox

CirculoGene Theranostics

Birmingham, US · Founded 2015 · Delaware corporation

Find your way into CirculoGene Theranostics

138 people in our graph share verified history with the CirculoGene Theranostics team — schools, employers, funds. One of them is your warm intro.

Will McGinnisunlockedknows Michael V. Mullen · together at Auburn University
×9knows the team · via Auburn University
×2knows the team · via University of Alabama at Birmingham
Healthtech

Founders & leadership

MVMichael V. Mullen
Michael V. MulleninExecutiveMichael V. Mullen holds degrees in Accounting and Finance from University of Alabama at Birmingham and Biology from Auburn University. He has built teams in specialty diagnostics and biotechnology and has experience in finance, capital raising, sales, and business development.
SR
Scott RezekExecutive
CY
Chen YehNamed on SEC filing

Board

CC
Charles ClarkBoard director
EF
Edwin FinchBoard director

Reported raises · per SEC filings

Form D private placements

$10.9M disclosed across 10 rounds · 2015–2023

▶$2MraisedMar 2023 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard BrandExecutive Officer
  • Mike MullenExecutive Officer
Offering amount
$5M
Amount sold
$2M
Placement agents
Arcadia Securities, LLC
First sale
Mar 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.6MraisedSep 2022 · 9 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard BrandExecutive Officer
  • Mike MullenExecutive Officer
Offering amount
$5M
Amount sold
$2.6M
Placement agents
Arcadia Securities, LLC
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$250KraisedJan 2021 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Charles A. MusialExecutive Officer
  • Michael V. MullenExecutive Officer, Director
  • Harold B. DunnDirector
  • Daniel ColemanDirector
  • Thomas A. SatterfieldDirector
  • Chen-Hsiung YehExecutive Officer
  • Stephen EckDirector
  • Robert GarvieDirector
  • Scott RezekExecutive Officer
  • James E. CantrellDirector
Offering amount
$15M
Amount sold
$250K
Finders' fees
$17.5K
Placement agents
Arcadia Securities, LLC
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$330KraisedSep 2019 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael V MullenExecutive Officer, Director
  • Edwin FinchDirector
  • Charles ClarkDirector
  • Chen YehExecutive Officer
  • Scott RezekExecutive Officer
  • Stephen EckDirector
  • Daniel ColemanDirector
  • Robert GarvieDirector
Offering amount
$2M
Amount sold
$330K
First sale
Sep 2019
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedNov 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chen YehExecutive Officer
  • Charles ClarkDirector
  • Robert GarvieDirector
  • Michael V MullenExecutive Officer, Director
  • Scott RezekExecutive Officer
  • Stephen EckDirector
  • Edwin FinchDirector
  • Daniel ColemanDirector
Offering amount
$3M
Amount sold
$2M
Minimum investment
$50K
First sale
Nov 2018
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedJan 2018 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott RezekExecutive Officer
  • Michael V MullenExecutive Officer, Director
  • Edwin W FinchDirector
  • Chen YehExecutive Officer
  • Charles ClarkDirector
Offering amount
$3M
Amount sold
$1M
First sale
Jan 2018
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$350KraisedSep 2017 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Chen YehExecutive Officer
  • Charles ClarkDirector
  • Michael V. MullenExecutive Officer, Director
  • Edwin W. FinchDirector
  • Scott RezekExecutive Officer
Offering amount
$700K
Amount sold
$350K
First sale
Sep 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$355KraisedMar 2017 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Edwin FinchDirector
  • Chen YehExecutive Officer
  • Scott RezekExecutive Officer
  • Michael V. MullenExecutive Officer, Director
  • Charles ClarkDirector
Offering amount
$800K
Amount sold
$355K
First sale
Mar 2017
Incorporated
Limited Liability Company, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has CirculoGene Theranostics raised?
CirculoGene Theranostics has disclosed $10.9M raised across 10 rounds.
Where is CirculoGene Theranostics headquartered?
CirculoGene Theranostics is headquartered in Birmingham, US.